Sign In
Buy AWH
$0.0820
+0 (+0%)
At Close: Jul 30, 2025
Aspira Women's Health Announces Appointment of Jane Pine Wood to the Board of Directors
04:01pm, Tuesday, 15'th Jul 2025
AUSTIN, TX / ACCESS Newswire / July 15, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (QTCQB:AWHL), an AI enhanced bio-analytical based women's health company focused on delivering the
AWH to Hold Second Quarter 2025 Earnings Conference Call on Thursday, August 7, 2025
08:00am, Thursday, 10'th Jul 2025
NEW YORK , July 10, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, toda
Aspira Women's Health Partners with Dorsata to Offer Access to 300+ Women's Health Practices, 1.5 Million + New Patients
07:00am, Tuesday, 17'th Jun 2025
Aspira and Dorsata Launch Clinical Workflow Tool for Adnexal Masses, Now Live for All Dorsata Clients, Adnexal Mass Evidence-Based Decision Support AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / Ju
Aspira Announces First Quarter 2025 Financial Results and Provides Business Update
07:55am, Monday, 19'th May 2025
AUSTIN, TX / ACCESS Newswire / May 19, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasive gy
AWH ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS
04:00pm, Monday, 12'th May 2025
First Quarter 2025 Net Revenue of $128.0 million and Adjusted EBITDA 1 of $27.0 million Generated Positive Cash from Operations of $5.9 million, the Ninth Consecutive Quarter of Positive Operating C
AWH to Hold First Quarter 2025 Earnings Conference Call on Monday, May 12, 2025
07:15am, Monday, 28'th Apr 2025
NEW YORK , April 28, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, toda
Aspira Women's Health Inc. to Begin Trading April 17th On OTC Under the Symbol "AWHL"
06:00am, Thursday, 17'th Apr 2025
SHELTON, CT / ACCESS Newswire / April 17, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gyneco
Aspira Women's Health Inc. Announces Receipt of Delisting Notification from Nasdaq
04:00pm, Wednesday, 16'th Apr 2025
SHELTON, CT / ACCESS Newswire / April 16, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gyneco
Aspira Appoints Three New Directors, Executes $2.0 Million Equity Purchase Agreement
07:00am, Tuesday, 08'th Apr 2025
New Directors Bring Extensive Commercial Healthcare Relationships to Expand Business Development Opportunities. AUSTIN, TX / ACCESS Newswire / April 8, 2025 / Aspira Women's Health Inc. ("Aspira"
Aspira Receives $1.5 million Milestone Payment from the ARPA-H Sprint for Women's Health Award
08:00am, Monday, 31'st Mar 2025
The Company Successfully Reaches the Second Milestone of ARPA-H $10 Million Award AUSTIN, TX / ACCESS Newswire / March 31, 2025 / Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytica
Aspira Women's Health Reports Fourth Quarter and Full Year 2024 Financial Results
04:00pm, Thursday, 27'th Mar 2025
Record 2024 OvaSuite revenue of $9.2 million and volume of 24,305 units sold AUSTIN, TX / ACCESS Newswire / March 27, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (Nasdaq:AWH), a bio-
AWH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
04:00pm, Wednesday, 12'th Mar 2025
Full Year 2024 Net Revenue Increased 8% Year-over-Year to $562 million Full Year 2024 Adjusted EBITDA 1 Increased 9% Year-over-Year to $116 million Second Full Year of Positive Cash from Operations
Aspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible Notes
08:00am, Tuesday, 11'th Mar 2025
AUSTIN, TX / ACCESS Newswire / March 11, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecol
AWH to Hold Fourth Quarter 2024 Earnings Conference Call on Wednesday March 12, 2025
05:00pm, Tuesday, 18'th Feb 2025
NEW YORK , Feb. 18, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, today
Aspira Women's Health Announces Appointment of Ellen Beausang to the Board of Directors
08:30am, Tuesday, 11'th Feb 2025
AUSTIN, TX / ACCESS Newswire / February 11, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gyne
